Unknown

Dataset Information

0

Expanding transcatheter aortic valve replacement into uncharted indications.


ABSTRACT: Since the first-in-man transcatheter delivery of an aortic valve prosthesis in 2002, the landscape of aortic stenosis therapeutics has shifted dramatically. While initially restricted to non-surgical cases, progressive advances in transcatheter aortic valve replacement and our understanding of its safety and efficacy have expanded its use in intermediate and possibly low surgical risk patients. In this review, we explore the past, present, and future of transcatheter aortic valve replacement.

SUBMITTER: Kang G 

PROVIDER: S-EPMC5943666 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Expanding transcatheter aortic valve replacement into uncharted indications.

Kang Guson G   Kim Juyong Brian JB  

The Korean journal of internal medicine 20180320 3


Since the first-in-man transcatheter delivery of an aortic valve prosthesis in 2002, the landscape of aortic stenosis therapeutics has shifted dramatically. While initially restricted to non-surgical cases, progressive advances in transcatheter aortic valve replacement and our understanding of its safety and efficacy have expanded its use in intermediate and possibly low surgical risk patients. In this review, we explore the past, present, and future of transcatheter aortic valve replacement. ...[more]

Similar Datasets

| S-EPMC4959424 | biostudies-literature
| S-EPMC8302783 | biostudies-literature
| S-EPMC11002802 | biostudies-literature
| S-EPMC8642721 | biostudies-literature
| S-EPMC8183801 | biostudies-literature
| S-EPMC7237626 | biostudies-literature
| S-EPMC9912968 | biostudies-literature
| S-EPMC6790961 | biostudies-literature
| S-EPMC4862065 | biostudies-other